European Society of Toxicology In Vitro > Uncategorized > ILSI survey on human tissue applications.
27 May 2024

ILSI survey on human tissue applications.

ILSI Europe is proud to contribute to ESTIV 2024 by actively engaging ESTIV members and followers in a questionnaire and short survey on human tissue applications. These resources, curated by the Expert Group on Human Tissue appointed by ILSI Europe’s Alternatives to Animal Testing Task Force, aim to foster engagement and ignite fresh perspectives. Your participation in both endeavours will enhance the discourse on this subject and drive us towards innovative solutions.

To take part in the short survey, click here.

To engage in the questionnaire, please follow the link below:

Alternatives to Animal Testing Task Force Human Tissues Expert Group
The Expert Group on Human Tissues from ILSI Europe, has developed a questionnaire to explore the viability of using human tissues as a replacement for animal testing. Go to thiss way

Please submit your responses by June 20, and feel free to share this content within your network.

Finally, don’t hesitate to register for ILSI’s upcoming webinars in Toxicological Hazard and Risk Assessment: Exploring Innovative Testing and NAMs

📝 To register, please click on the links below:

Webinar on 28 May | 14:00-16:00 CET: https://us06web.zoom.us/meeting/register/tZYuc-muqz0jGNwsHcUPEoYUDagWJ_sV9L_e

Webinar on 30 May | 14:00-16:00 CET:  https://us06web.zoom.us/meeting/register/tZwvfu6hqz8tGtDn1aZFhvKnrfgpv1xmUegE

Your ILSI Team

Related content

Celebrating Talents in Toxicology: ESTIV Awards at ASCCT 2024

We are thrilled to announce the recipients of the ESTIV Awards recognizing outstanding early-career scientists at last week’s ASCCT Congress

ASCCT-ESTIV Award Winners Series: Dr. Eliska Kuchovska & Tiago Marques Pedro

  • News

Registration is open for the next joint ASCCT-ESTIV webinar featuring two excellent early career scientists and award recipients

Welcoming Luiz Ladeira to the ESTIV Board!

  • News

We are excited to announce that Dr. Luiz Ladeira has joined the ESTIV Board! Luiz brings exceptional expertise in physiological maps and AOP research, and a strong commitment to advancing in vitro and in silico toxicology.

Silver Sponsor

Memorandum of Understanding